Firdapse (Amifampridine) Approved for Rare Autoimmune Disorder

THURSDAY, Nov. 29, 2018 -- Firdapse (amifampridine) tablets have been approved by the U.S. Food and Drug Administration for adults with Lambert-Eaton myasthenic syndrome (LEMS). It ' s the first agency-sanctioned treatment for the autoimmune disease...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news